Literature DB >> 2354136

Quantitative analysis of collagen content and amino acids in trabecular meshwork.

I Finkelstein1, G E Trope, P K Basu, S M Hasany, W S Hunter.   

Abstract

The purpose of this study was to compare collagen content in the TM of normal and glaucomatous eyes, and to establish whether collagen levels change with age. Collagen content was measured in 30 normal and 27 age matched glaucoma trabeculectomy specimens by the sirius red dye binding technique, and in 14 normal and 15 age matched glaucoma specimens by amino acid analysis. Both dye binding data and amino acid analysis showed no statistical difference between normal and glaucoma samples. Age had no significant effect on mean optical densities or on the collagen-specific amino acids proline, hydroxyproline, and hydroxylysine. Amino acid variability, however, was statistically different between the two groups. These results indicate that mean collagen levels in the trabecular meshwork of glaucomatous eyes do not differ from those in normal eyes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354136      PMCID: PMC1042098          DOI: 10.1136/bjo.74.5.280

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Collagen staining in corneal tissues.

Authors:  B Y Yue; J Sugar; K Schrode
Journal:  Curr Eye Res       Date:  1986-08       Impact factor: 2.424

2.  Collagen distribution in the lamina cribrosa and the trabecular meshwork of the human eye.

Authors:  M Rehnberg; T Ammitzböll; B Tengroth
Journal:  Br J Ophthalmol       Date:  1987-12       Impact factor: 4.638

Review 3.  Structure, function and ageing of the collagens of the eye.

Authors:  A J Bailey
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

4.  A simple and sensitive method for the quantitative estimation of collagen.

Authors:  L C Junquiera; L C Junqueira; R R Brentani
Journal:  Anal Biochem       Date:  1979-04-01       Impact factor: 3.365

5.  Age-related changes in the composition of proteins in the trabecular meshwork of the human eye.

Authors:  H J Horstmann; J W Rohen; K Sames
Journal:  Mech Ageing Dev       Date:  1983-02       Impact factor: 5.432

6.  [Collagen metabolism in primary glaucoma].

Authors:  T I Eroshevskiĭ; T Ia Sviatkovskaia
Journal:  Oftalmol Zh       Date:  1979

7.  [Corneoscleral trabecular collagen. Ultrastructural changes and immunotyping in chronic and cortisone-induced glaucoma].

Authors:  S Stocker; J A Grimaud; M Druguet; M Bernard; L Durand
Journal:  J Fr Ophtalmol       Date:  1980       Impact factor: 0.818

8.  A comparative analysis of the collagen type and distribution in the trabecular meshwork, sclera, lamina cribrosa and the optic nerve in the human eye.

Authors:  B Tengroth; M Rehnberg; T Amitzboll
Journal:  Acta Ophthalmol Suppl       Date:  1985

9.  An early-onset retinal dystrophy with dominant inheritance in the Abyssinian cat. Clinical and pathological findings.

Authors:  R Curtis; K C Barnett; A Leon
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-01       Impact factor: 4.799

10.  Changes in the content and composition of collagen in the glaucomatous eye--basis for a new hypothesis for the genesis of chronic open angle glaucoma--a preliminary report.

Authors:  B Tengroth; T Ammitzbøll
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-12
  10 in total
  2 in total

1.  Glycans of the trabecular meshwork in primary open angle glaucoma.

Authors:  S A Chapman; R E Bonshek; R W Stoddart; E O'Donoghue; K Goodall; D McLeod
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Alterations in proteome of human sclera associated with primary open-angle glaucoma involve proteins participating in regulation of the extracellular matrix.

Authors:  Elena N Iomdina; Natalya K Tikhomirova; Alexander M Bessmertny; Marina V Serebryakova; Viktoriia E Baksheeva; Arthur O Zalevsky; Vladislav I Kotelin; Olga A Kiseleva; Sbrui M Kosakyan; Andrey A Zamyatnin; Pavel P Philippov; Evgeni Yu Zernii
Journal:  Mol Vis       Date:  2020-09-02       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.